ARQT
Arcutis Biotherapeutics Inc
25.20$
-0.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 124.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,504.1 | 244.8 | 104.0 | 50.1 | 6.7 | 5.0 | 10.3 | 8.7 | 8.3 | 8.6 | 9.2 | 6.7 | 7.9 | 10.5 | 7.3 | 7.7 | |
| – | – | – | – | – | – | – | – | 4.7 | 5.4 | 6.4 | 4.5 | 3.0 | 3.3 | 3.3 | 3.5 | 3.8 | 5.6 | 4.0 | 4.3 | 4.8 | 7.2 | 7.0 | 3.3 | 4.9 | 6.2 | 7.4 | 10.7 | 13.8 | 12.8 | 15.9 | 20.8 | 16.1 | 16.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,663.9 | 284.0 | 122.3 | 58.2 | 8.6 | 6.9 | 10.5 | 9.6 | 8.8 | 8.7 | 9.5 | 6.9 | 8.1 | 10.6 | 7.5 | 7.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,519.0 | 208.1 | 82.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 113.4 | 90.9 | |
| – | – | – | – | – | – | – | – | -5.0% | -6.6% | -8.9% | -9.4% | -10.2% | -11.0% | -13.1% | -16.9% | -19.1% | -19.4% | -24.0% | -31.1% | -45.2% | -53.0% | -80.2% | -83.5% | -18.1% | -15.4% | -14.5% | -7.0% | -5.9% | -4.0% | -1.5% | -0.2% | 0.9% | 1.1% | |
| Margins | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -30.1% | 67.0% | 72.6% | 80.2% | 93.4% | 91.6% | 93.0% | 92.3% | 89.6% | 90.3% | 88.4% | 89.1% | 90.0% | 90.2% | 90.9% | 91.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -41,998.5% | -8,183.0% | -4,875.0% | -2,712.5% | -506.4% | -404.5% | -184.7% | -136.1% | -131.2% | -65.3% | -57.0% | -32.6% | -12.0% | -3.3% | 0.8% | 7.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -42,864.1% | -8,449.8% | -5,054.4% | -2,834.8% | -545.5% | -439.2% | -204.4% | -150.5% | -141.0% | -71.3% | -61.0% | -35.4% | -13.9% | -4.3% | -0.6% | 6.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -36,107.6% | -7,623.4% | -4,705.8% | -2,651.0% | -535.1% | -415.2% | -186.7% | -134.0% | -121.0% | -59.7% | -54.8% | -27.1% | -12.0% | -1.7% | 6.5% | 8.4% | |
| Returns | ||||||||||||||||||||||||||||||||||
| – | – | – | – | -47.5% | -84.0% | – | -41.4% | -26.2% | -43.3% | -66.0% | -50.1% | -31.9% | -36.3% | -46.6% | -69.3% | -92.5% | -133.1% | -114.8% | -148.6% | -233.9% | -410.5% | -572.6% | -295.2% | -96.7% | -106.6% | -124.8% | -88.9% | -90.9% | -67.1% | -28.0% | -8.5% | -1.3% | 12.9% | |
| – | – | – | -37.7% | -60.0% | -73.9% | -123.8% | -39.2% | -24.9% | -39.0% | -57.7% | -45.5% | -30.5% | -34.7% | -43.7% | -50.6% | -64.4% | -86.5% | -61.1% | -69.3% | -86.1% | -103.0% | -91.3% | -76.7% | -45.4% | -44.7% | -44.7% | -40.1% | -37.7% | -26.5% | -11.9% | -3.7% | -0.5% | 5.8% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | -13 | -23 | -63 | -191 | -171 | -46 | – | – | -91 | -53 | -25 | 2.2 | 12 | 116 | 145 | 118 | 95 | 94 | 114 | 13 | 120 | 71 | 37 | 55 | 35 | 61 | 66 | 75 | 75 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 25.1 | 5.0 | 1.7 | |
| – | – | – | -46.9% | 126.4% | 88.0% | -187.1% | 94.8% | 95.1% | 90.1% | 87.4% | 90.7% | 95.7% | 95.7% | 93.8% | 72.9% | 69.7% | 65.0% | 53.2% | 46.6% | 36.8% | 25.1% | 15.9% | 26.0% | 47.0% | 41.9% | 35.8% | 45.2% | 41.5% | 39.4% | 42.6% | 43.8% | 41.2% | 45.2% | |
| – | – | – | – | – | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | 0.0 | 0.2 | 0.3 | 0.4 | 0.7 | 0.9 | 1.4 | 2.5 | 4.3 | 2.3 | 0.9 | 1.1 | 1.3 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | 0.6 | 0.5 | |
| Per Share | ||||||||||||||||||||||||||||||||||
| – | – | – | -0.53 | -0.62 | -0.74 | -0.97 | -1.10 | -1.67 | -2.41 | -3.03 | -3.16 | -3.04 | -3.01 | -3.37 | -4.11 | -4.65 | -5.06 | -5.44 | -5.11 | -5.34 | -5.38 | -4.33 | -2.83 | -1.96 | -1.61 | -1.57 | -1.16 | -1.03 | -0.73 | -0.33 | -0.12 | -0.02 | 0.21 | |
| – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.06 | 0.11 | 0.19 | 0.79 | 0.64 | 0.96 | 1.07 | 1.12 | 1.62 | 1.69 | 2.07 | 2.39 | 2.77 | 3.21 | 3.41 | |
| 2.05 | – | – | -0.66 | 1.30 | 0.88 | -1.46 | 2.66 | 6.39 | 5.56 | 4.58 | 6.30 | 9.54 | 8.29 | 7.25 | 5.93 | 5.02 | 3.80 | 4.74 | 3.44 | 2.28 | 1.31 | 0.76 | 0.96 | 2.03 | 1.51 | 1.26 | 1.30 | 1.13 | 1.09 | 1.19 | 1.40 | 1.47 | 1.62 | |
| – | – | – | -0.39 | -0.50 | -0.64 | -0.89 | -1.13 | -1.50 | -1.98 | -2.60 | -2.65 | -2.95 | -2.99 | -3.12 | -3.50 | -3.68 | -4.13 | -4.59 | -4.61 | -4.98 | -5.03 | -4.25 | -2.67 | -1.79 | -1.43 | -1.35 | -0.97 | -0.93 | -0.56 | -0.29 | -0.05 | 0.21 | 0.29 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.